跳至主要内容
临床试验/ISRCTN99035319
ISRCTN99035319已完成未知

A multi-centre randomised trial comparing EUS guided fine needle aspiration cytology (FNAC) with fine needle aspiration biopsy (FNAB) in sampling solid pancreatic mass lesions

niversity of Nottingham (UK)0 个研究点目标入组 268 人开始时间: 2013年6月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
268

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult patients 18 years and above with a solid pancreatic mass of any size, needing to undergo EUS examination to collect sample for diagnosis. Definition of a solid pancreatic mass will be based on an ultrasound, CT scan or on the findings of a prior EUS.
  • 2. Patients should have the ability and be willing to give informed consent.

排除标准

  • 1. Cystic lesions of the pancreas.
  • 2. Patients known to be intolerant to endoscopy.
  • 3. Patients not clinically fit for endoscopy as judged by their cariong team.
  • 4. Patients on anticoagulation therapy.
  • 5. Patients already participating in another trial.

研究者

发起方
niversity of Nottingham (UK)

相似试验

进行中(未招募)
1 期
A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus placebo vs. pegylated interfeorn-alfa-2a plus tenofovir for the treatment of chronic delta hepatitis- The Hep-Net International Delta hepatits Interventional Trial II (HIDIT-II) - HIDIT-IITo compare the virological efficacy (HDV-RNA) and safety of 96 weeks of therapy with pegylated interferon-alfa-2a plus tenovofir to 96 weeks of therapy with pegylated interferon-alfa-2a plus placebo for the treatment with chronic delta hepatits virus.MedDRA version: 9.1Level: LLTClassification code 10047455Term: Viral hepatitis B without mention of hepatic coma, with hepatitis delta
EUCTR2008-005560-13-GRMedizinische Hochschule Hannover70
已完成
不适用
A multicenter randomised study comparing the efficacy of adefovir dipivoxil versus pegylated interferon alpha-2a plus placebo versus adefovir dipivoxil plus peglyated interferon alpha-2a for the treatment of chronic delta hepatitisAdults with chronic delta hepatitisInfections and Infestations
ISRCTN83587695Hannover Medical School (MHH) (Germany)69
进行中(未招募)
1 期
Treatment of delta hepatitis with pegylated interferon-alfa-2a and tenofovir or placeboTo compare the virological efficacy (HDV-RNA) and safety of 96 weeks of therapy with pegylated interferon-alfa-2a plus tenovofir to 96 weeks of therapy with pegylated interferon-alfa-2a plus placebo for the treatment with chronic delta hepatits virus.MedDRA version: 15.1Level: LLTClassification code 10047455Term: Viral hepatitis B without mention of hepatic coma, with hepatitis deltaSystem Organ Class: 100000004862
EUCTR2008-005560-13-DEMedizinische Hochschule Hannover70
已完成
不适用
A randomized, multi-center trial to compare the efficacy of once-daily insulin detemir and biphasic insulin aspart-30 in Japanese type 2 diabetes patients with oral hypoglycaemic agents therapy.Type 2 DM
JPRN-UMIN000004396The Jikei University School of Medicine, Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine100
尚未招募
不适用
a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
JPRN-UMIN000039169ational cancer center east hospital colorectal surgery1,104